APT Medical (SHA:688617) estimated up to 104.5 million yuan in routine related-party transactions in 2026, according to a Wednesday filing with the Shanghai bourse.
About 61.5 million yuan will involve Mindray Bio-Medical Electronics, while 43.0 million yuan will involve other related entities, the filing said.
Shares of the medical device manufacturer rose 2% in recent trade.